RESUMEN
Starting in early 2020, the COVID-19 pandemic has been responsible, worldwide, for millions of deaths and patients with long-COVID syndrome. In an attempt to stop the spread of the virus, the blanket administration of COVID-19 vaccines proved to be the most effective measure, yet the existence and availability of functional vaccines did not and, still, do not ensure the willingness and intent of people to be vaccinated. This study assessed the similarities and differences in vaccine fears and vaccine hesitancy through between clusters of subjects: people that were not infected with COVID-19, people that had COVID but did not develop long-lasting symptoms, and people that were infected with COVID and developed long-COVID syndrome. From the sample of 1111 Italian people, it was found that individuals who experienced mild symptoms showed higher vaccine hesitancy (confidence, complacency, and collective responsibility) than those who did not contract COVID-19. People affected by long-COVID showed a lower overall hesitancy than individuals who had COVID-19 without incurring long-lasting symptoms and, thus, essentially resembled people who had no experience of COVID-19 infection in terms of the vaccine hesitancy scores. Vaccine fear remained unchanged across all three of the examined clusters.
Asunto(s)
COVID-19 , Vacunas , Humanos , COVID-19/epidemiología , COVID-19/prevención & control , Vacunas contra la COVID-19/uso terapéutico , Vacilación a la Vacunación , Pandemias , Aceptación de la Atención de Salud , Vacunación , Miedo , Síndrome , Síndrome Post Agudo de COVID-19RESUMEN
This study seeks to analyse the relationship between needle-related fear (NF) and vaccination fear (VF), vaccination intention (VI), and the most commonly declared reasons for avoiding vaccination (RAV). The aim was to expand the information on the subject in a pandemic context. Just before starting the vaccination plan. A cross-sectional survey was applied to a sample (N = 2,175) of adult Spanish citizens (37.60 ± 12.98 years), of both sexes (women: 67.3%). Descriptive, correlational, and regression analysis was carried out. For NF, the prevalence was 5.1%, with being a woman, aged between 20 and 40 years old, and without dependents in charge as risk factors. NF presented low but significant relationships with VF, VI, and RAVs (except the one related to vaccine efficacy). This relationship was positive with NF and RAVs and negative with VI. The results are discussed. Actions in NF are recommended to reduce VF and RAVs and increase VI. (AU)
El objetivo de este estudio es analizar la relación entre el miedo a la aguja (MA) y el miedo a la vacunación (MV), la intención de vacunarse (IV) y los motivos más comúnmente alegados para evitarlo (MEV). Se pretende ampliar la información sobre el tema en un contexto de pandemia. Justo antes de iniciar el plan de vacunación. Se aplicó una encuesta transversal a una muestra (N = 2,175) de ciudadanos españoles adultos (37.60 ± 12.98 años), de ambos sexos (mujeres: 67.3%). Se realizó análisis descriptivo, correlacional y de regresión. Para el MV la prevalencia fue de 5.1%, siendo factores de riesgo ser mujer, entre 20 y 40 años y sin dependientes a cargo. La relación entre MA y MV, IV y MEV (excepto la relacionada con la eficacia de la vacuna) era escasa aunque significativa. Esta relación fue positiva con el MA y los MEV y negativa con el MV. Se comentan los resultados y se recomienda actuar sobre el MA para reducir el MV y los MEV y aumentar la IV. (AU)